Report Detail

Medical Devices & Consumables Global Immune in Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4582503
  • |
  • 29 March, 2024
  • |
  • Global
  • |
  • 154 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Immune in Vitro Diagnostics market size was valued at USD 24060 million in 2023 and is forecast to a readjusted size of USD 37550 million by 2030 with a CAGR of 6.6% during review period.
Immune in vitro diagnostics (IVD) involve the examination of components related to the immune system, often using laboratory tests performed on biological samples taken from the human body. These tests play a crucial role in understanding the immune response, diagnosing immunological disorders, monitoring the effectiveness of treatments, and assessing overall immune health.

The Immune In Vitro Diagnostics market is propelled by a growing demand for advanced diagnostic tools to assess the immune system's functionality and response. With the increasing incidence of immune-related disorders, including autoimmune diseases and allergies, there is a heightened need for accurate and timely diagnostics. Immune in vitro diagnostic devices, such as immunoassays, flow cytometry, and molecular diagnostics, play a crucial role in evaluating immune biomarkers. The market is driven by ongoing research in immunology, leading to the development of more specific and sensitive diagnostic technologies. Additionally, a focus on personalized medicine and treatment strategies contributes to the continuous evolution and adoption of immune in vitro diagnostics in clinical practice.
The Global Info Research report includes an overview of the development of the Immune in Vitro Diagnostics industry chain, the market status of Hepatitis Test (Consumables, Equipment), STD Testing (Consumables, Equipment), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immune in Vitro Diagnostics.
Regionally, the report analyzes the Immune in Vitro Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immune in Vitro Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immune in Vitro Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immune in Vitro Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Consumables, Equipment).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immune in Vitro Diagnostics market.
Regional Analysis: The report involves examining the Immune in Vitro Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immune in Vitro Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immune in Vitro Diagnostics:
Company Analysis: Report covers individual Immune in Vitro Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immune in Vitro Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hepatitis Test, STD Testing).
Technology Analysis: Report covers specific technologies relevant to Immune in Vitro Diagnostics. It assesses the current state, advancements, and potential future developments in Immune in Vitro Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immune in Vitro Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immune in Vitro Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Consumables
Equipment
Market segment by Application
Hepatitis Test
STD Testing
Tumor Detection
Other
Market segment by players, this report covers
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immune in Vitro Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immune in Vitro Diagnostics, with revenue, gross margin and global market share of Immune in Vitro Diagnostics from 2019 to 2024.
Chapter 3, the Immune in Vitro Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immune in Vitro Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immune in Vitro Diagnostics.
Chapter 13, to describe Immune in Vitro Diagnostics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Immune in Vitro Diagnostics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immune in Vitro Diagnostics by Type
    • 1.3.1 Overview: Global Immune in Vitro Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Immune in Vitro Diagnostics Consumption Value Market Share by Type in 2023
    • 1.3.3 Consumables
    • 1.3.4 Equipment
  • 1.4 Global Immune in Vitro Diagnostics Market by Application
    • 1.4.1 Overview: Global Immune in Vitro Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hepatitis Test
    • 1.4.3 STD Testing
    • 1.4.4 Tumor Detection
    • 1.4.5 Other
  • 1.5 Global Immune in Vitro Diagnostics Market Size & Forecast
  • 1.6 Global Immune in Vitro Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Immune in Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Immune in Vitro Diagnostics Market Size by Region, (2019-2030)
    • 1.6.3 North America Immune in Vitro Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Immune in Vitro Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Immune in Vitro Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Immune in Vitro Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Immune in Vitro Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Immune in Vitro Diagnostics Product and Solutions
    • 2.1.4 Roche Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Siemens
    • 2.2.1 Siemens Details
    • 2.2.2 Siemens Major Business
    • 2.2.3 Siemens Immune in Vitro Diagnostics Product and Solutions
    • 2.2.4 Siemens Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Siemens Recent Developments and Future Plans
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Immune in Vitro Diagnostics Product and Solutions
    • 2.3.4 Abbott Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Abbott Recent Developments and Future Plans
  • 2.4 Danaher
    • 2.4.1 Danaher Details
    • 2.4.2 Danaher Major Business
    • 2.4.3 Danaher Immune in Vitro Diagnostics Product and Solutions
    • 2.4.4 Danaher Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Danaher Recent Developments and Future Plans
  • 2.5 Thermo Fisher
    • 2.5.1 Thermo Fisher Details
    • 2.5.2 Thermo Fisher Major Business
    • 2.5.3 Thermo Fisher Immune in Vitro Diagnostics Product and Solutions
    • 2.5.4 Thermo Fisher Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Thermo Fisher Recent Developments and Future Plans
  • 2.6 BioMerieux
    • 2.6.1 BioMerieux Details
    • 2.6.2 BioMerieux Major Business
    • 2.6.3 BioMerieux Immune in Vitro Diagnostics Product and Solutions
    • 2.6.4 BioMerieux Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 BioMerieux Recent Developments and Future Plans
  • 2.7 Bio-Rad
    • 2.7.1 Bio-Rad Details
    • 2.7.2 Bio-Rad Major Business
    • 2.7.3 Bio-Rad Immune in Vitro Diagnostics Product and Solutions
    • 2.7.4 Bio-Rad Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Bio-Rad Recent Developments and Future Plans
  • 2.8 BD
    • 2.8.1 BD Details
    • 2.8.2 BD Major Business
    • 2.8.3 BD Immune in Vitro Diagnostics Product and Solutions
    • 2.8.4 BD Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 BD Recent Developments and Future Plans
  • 2.9 KHB
    • 2.9.1 KHB Details
    • 2.9.2 KHB Major Business
    • 2.9.3 KHB Immune in Vitro Diagnostics Product and Solutions
    • 2.9.4 KHB Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 KHB Recent Developments and Future Plans
  • 2.10 Daan Gene
    • 2.10.1 Daan Gene Details
    • 2.10.2 Daan Gene Major Business
    • 2.10.3 Daan Gene Immune in Vitro Diagnostics Product and Solutions
    • 2.10.4 Daan Gene Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Daan Gene Recent Developments and Future Plans
  • 2.11 Leadman
    • 2.11.1 Leadman Details
    • 2.11.2 Leadman Major Business
    • 2.11.3 Leadman Immune in Vitro Diagnostics Product and Solutions
    • 2.11.4 Leadman Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Leadman Recent Developments and Future Plans
  • 2.12 Zhongsheng
    • 2.12.1 Zhongsheng Details
    • 2.12.2 Zhongsheng Major Business
    • 2.12.3 Zhongsheng Immune in Vitro Diagnostics Product and Solutions
    • 2.12.4 Zhongsheng Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Zhongsheng Recent Developments and Future Plans
  • 2.13 Bsbe
    • 2.13.1 Bsbe Details
    • 2.13.2 Bsbe Major Business
    • 2.13.3 Bsbe Immune in Vitro Diagnostics Product and Solutions
    • 2.13.4 Bsbe Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Bsbe Recent Developments and Future Plans
  • 2.14 Maccura
    • 2.14.1 Maccura Details
    • 2.14.2 Maccura Major Business
    • 2.14.3 Maccura Immune in Vitro Diagnostics Product and Solutions
    • 2.14.4 Maccura Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Maccura Recent Developments and Future Plans
  • 2.15 Hitachi
    • 2.15.1 Hitachi Details
    • 2.15.2 Hitachi Major Business
    • 2.15.3 Hitachi Immune in Vitro Diagnostics Product and Solutions
    • 2.15.4 Hitachi Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Hitachi Recent Developments and Future Plans
  • 2.16 Canon
    • 2.16.1 Canon Details
    • 2.16.2 Canon Major Business
    • 2.16.3 Canon Immune in Vitro Diagnostics Product and Solutions
    • 2.16.4 Canon Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Canon Recent Developments and Future Plans
  • 2.17 Sysmex
    • 2.17.1 Sysmex Details
    • 2.17.2 Sysmex Major Business
    • 2.17.3 Sysmex Immune in Vitro Diagnostics Product and Solutions
    • 2.17.4 Sysmex Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Sysmex Recent Developments and Future Plans
  • 2.18 Auto Bio
    • 2.18.1 Auto Bio Details
    • 2.18.2 Auto Bio Major Business
    • 2.18.3 Auto Bio Immune in Vitro Diagnostics Product and Solutions
    • 2.18.4 Auto Bio Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Auto Bio Recent Developments and Future Plans
  • 2.19 Mindray
    • 2.19.1 Mindray Details
    • 2.19.2 Mindray Major Business
    • 2.19.3 Mindray Immune in Vitro Diagnostics Product and Solutions
    • 2.19.4 Mindray Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Mindray Recent Developments and Future Plans
  • 2.20 Bgi
    • 2.20.1 Bgi Details
    • 2.20.2 Bgi Major Business
    • 2.20.3 Bgi Immune in Vitro Diagnostics Product and Solutions
    • 2.20.4 Bgi Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.20.5 Bgi Recent Developments and Future Plans
  • 2.21 Wondfo
    • 2.21.1 Wondfo Details
    • 2.21.2 Wondfo Major Business
    • 2.21.3 Wondfo Immune in Vitro Diagnostics Product and Solutions
    • 2.21.4 Wondfo Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.21.5 Wondfo Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immune in Vitro Diagnostics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Immune in Vitro Diagnostics by Company Revenue
    • 3.2.2 Top 3 Immune in Vitro Diagnostics Players Market Share in 2023
    • 3.2.3 Top 6 Immune in Vitro Diagnostics Players Market Share in 2023
  • 3.3 Immune in Vitro Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Immune in Vitro Diagnostics Market: Region Footprint
    • 3.3.2 Immune in Vitro Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Immune in Vitro Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immune in Vitro Diagnostics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Immune in Vitro Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Immune in Vitro Diagnostics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Immune in Vitro Diagnostics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Immune in Vitro Diagnostics Consumption Value by Type (2019-2030)
  • 6.2 North America Immune in Vitro Diagnostics Consumption Value by Application (2019-2030)
  • 6.3 North America Immune in Vitro Diagnostics Market Size by Country
    • 6.3.1 North America Immune in Vitro Diagnostics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Immune in Vitro Diagnostics Consumption Value by Type (2019-2030)
  • 7.2 Europe Immune in Vitro Diagnostics Consumption Value by Application (2019-2030)
  • 7.3 Europe Immune in Vitro Diagnostics Market Size by Country
    • 7.3.1 Europe Immune in Vitro Diagnostics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.3 France Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immune in Vitro Diagnostics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Immune in Vitro Diagnostics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Immune in Vitro Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Immune in Vitro Diagnostics Consumption Value by Region (2019-2030)
    • 8.3.2 China Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.5 India Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Immune in Vitro Diagnostics Consumption Value by Type (2019-2030)
  • 9.2 South America Immune in Vitro Diagnostics Consumption Value by Application (2019-2030)
  • 9.3 South America Immune in Vitro Diagnostics Market Size by Country
    • 9.3.1 South America Immune in Vitro Diagnostics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immune in Vitro Diagnostics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Immune in Vitro Diagnostics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Immune in Vitro Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Immune in Vitro Diagnostics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Immune in Vitro Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Immune in Vitro Diagnostics Market Drivers
  • 11.2 Immune in Vitro Diagnostics Market Restraints
  • 11.3 Immune in Vitro Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immune in Vitro Diagnostics Industry Chain
  • 12.2 Immune in Vitro Diagnostics Upstream Analysis
  • 12.3 Immune in Vitro Diagnostics Midstream Analysis
  • 12.4 Immune in Vitro Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Immune in Vitro Diagnostics. Industry analysis & Market Report on Immune in Vitro Diagnostics is a syndicated market report, published as Global Immune in Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Immune in Vitro Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report